The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis

Journal of Hepatology

Volumn 57, Issue 5, 2012, Pages 1029-1036

  Nouët, Yann ^a,b   Dahan, Jennifer ^a,b   Labalette, Charlotte ^a,b   Levillayer, Florence ^a,b   Julien, Boris ^b   Jouvion, Grégory ^a   Cairo, Stefano ^a,b   Vives, Francina Langa ^a   Ribeiro, Agnès ^c   Huerre, Michel ^a   Colnot, Sabine ^d   Perret, Christine ^d   Nhieu, Jeanne Tran Van ^e   Tordjmann, Thierry ^b   Buendia, Marie Annick ^a,b   Wei, Yu ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d INSTITUT COCHIN   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

Cirrhosis; Cyclin D1; Hepatocarcinogenesis; Liver regeneration; p53

Indexed keywords

BETA CATENIN; CELL PROTEIN; CYCLIN D1; MESSENGER RNA; PROTEIN FHL2; PROTEIN P53; TUBULIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ADENOMATOUS POLYPOSIS COLI GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; FHL2 GENE; GENE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HOMEOSTASIS; LIVER REGENERATION; LIVER WEIGHT; MALE; MOUSE; MUTANT; NONHUMAN; P53 GENE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DISEASE MODELS, ANIMAL; FEMALE; HEPATECTOMY; HOMEOSTASIS; HUMANS; LIM-HOMEODOMAIN PROTEINS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MICE; MICE, TRANSGENIC; MUSCLE PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867580851     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.06.035     Document Type: Article

References (32)

1. V. Wixler, D. Geerts, E. Laplantine, D. Westhoff, N. Smyth, and M. Aumailley The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes J Biol Chem 275 2000 33669 33678
2. J. Park, C. Will, B. Martin, L. Gullotti, N. Friedrichs, and R. Buettner Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins FASEB J 22 2008 2508 2520
3. A. Morlon, and P. Sassone-Corsi The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1 Proc Natl Acad Sci U S A 100 2003 3977 3982
4. C. Labalette, Y. Nouet, J. Sobczak-Thepot, C. Armengol, F. Levillayer, and M.C. Gendron The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation J Biol Chem 283 2008 15201 15208
5. J.M. Muller, U. Isele, E. Metzger, A. Rempel, M. Moser, and A. Pscherer FHL2, a novel tissue-specific coactivator of the androgen receptor EMBO J 19 2000 359 369
6. G.M. Fimia, D. De Cesare, and P. Sassone-Corsi A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM Mol Cell Biol 20 2000 8613 8622
7. B. Martin, R. Schneider, S. Janetzky, Z. Waibler, P. Pandur, and M. Kuhl The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts J Cell Biol 159 2002 113 122
8. Y. Wei, C.A. Renard, C. Labalette, Y. Wu, L. Levy, and C. Neuveut Identification of the LIM protein FHL2 as a coactivator of beta-catenin J Biol Chem 278 2003 5188 5194
9. N.H. Purcell, D. Darwis, O.F. Bueno, J.M. Muller, R. Schule, and J.D. Molkentin Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes Mol Cell Biol 24 2004 1081 1095
10. S. Bai, H. Kitaura, H. Zhao, J. Chen, J.M. Muller, and R. Schule FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner J Clin Invest 115 2005 2742 2751
11. C. Paul, M. Lacroix, I. Iankova, E. Julien, B.W. Schafer, and C. Labalette The LIM-only protein FHL2 is a negative regulator of E4F1 Oncogene 25 2006 5475 5484
12. L. Ding, Z. Wang, J. Yan, X. Yang, A. Liu, and W. Qiu Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway J Clin Invest 119 2009 349 361
13. D. Maetzel, S. Denzel, B. Mack, M. Canis, P. Went, and M. Benk Nuclear signalling by tumour-associated antigen EpCAM Nat Cell Biol 11 2009 162 171
14. C. Labalette, C.A. Renard, C. Neuveut, M.A. Buendia, and Y. Wei Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin Mol Cell Biol 24 2004 10689 10702
15. Y. Yang, H. Hou, E.M. Haller, S.V. Nicosia, and W. Bai Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation EMBO J 24 2005 1021 1032
16. J.M. Muller, E. Metzger, H. Greschik, A.K. Bosserhoff, L. Mercep, and R. Buettner The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus EMBO J 21 2002 736 748
17. U. Philippar, G. Schratt, C. Dieterich, J.M. Muller, P. Galgoczy, and F.B. Engel The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF Mol Cell 16 2004 867 880
18. H.V. Heemers, K.M. Regan, S.M. Dehm, and D.J. Tindall Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer Cancer Res 67 2007 10592 10599
19. F.A. Scholl, P. McLoughlin, E. Ehler, C. de Giovanni, and B.W. Schafer DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis J Cell Biol 151 2000 495 506
20. J. Wang, Y. Yang, H.H. Xia, Q. Gu, M.C. Lin, and B. Jiang Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis Gastroenterology 132 2007 1066 1076
21. C. Labalette, Y. Nouet, F. Levillayer, C. Armengol, C.A. Renard, and G. Soubigou The LIM-only protein FHL2 mediates Ras-induced transformation through cyclin D1 and p53 pathways PLoS One 3 2008 e3761
22. F. Mille, C. Thibert, J. Fombonne, N. Rama, C. Guix, and H. Hayashi The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex Nat Cell Biol 11 2009 739 746
23. C. Labalette, Y. Nouet, F. Levillayer, S. Colnot, J. Chen, and V. Claude Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice PLoS One 5 2010 e10371
24. J. Le Beyec, V. Chauffeton, H.Y. Kan, P.L. Janvier, C. Cywiner-Golenzer, and F.P. Chatelet The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV gene J Biol Chem 274 1999 4954 4961
25. S. Colnot, T. Decaens, M. Niwa-Kawakita, C. Godard, G. Hamard, and A. Kahn Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas Proc Natl Acad Sci U S A 101 2004 17216 17221
26. B. Bienz-Tadmor, R. Zakut-Houri, S. Libresco, D. Givol, and M. Oren The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element EMBO J 4 1985 3209 3213
27. V.R. Mas, D.G. Maluf, K.J. Archer, K. Yanek, X. Kong, and L. Kulik Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma Mol Med 15 2009 85 94
28. N.G. Deane, M.A. Parker, R. Aramandla, L. Diehl, W.J. Lee, and M.K. Washington Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice Cancer Res 61 2001 5389 5395
29. Z. Qian, L. Mao, A.A. Fernald, H. Yu, R. Luo, and Y. Jiang Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo Leukemia 23 2009 1650 1657
30. C.F. Ng, P.K. Ng, V.W. Lui, J. Li, J.Y. Chan, and K.P. Fung FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells Cancer Lett 304 2011 97 106
31. K.N. Nejak-Bowen, M.D. Thompson, S. Singh, W.C. Bowen Jr., M.J. Dar, and J. Khillan Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin Hepatology 51 2010 1603 1613
32. J. Etiemble, C. Degott, C.A. Renard, G. Fourel, B. Shamoon, and L. Vitvitski-Trepo Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion Oncogene 9 1994 727 737